Unlicensed Medicines – Global Access
Insight Blog
13 Apr 2018
Falsified Medicines; the Role of the Pharmacist in Raising Patient Awareness
Unlicensed Medicines – Managed Access
Video
23 Feb 2018
Opportunity and challenges associated with making medicines available in the AAA (Australasia, Africa and Asia)...
Unlicensed Medicines – Managed Access
Video
20 Feb 2018
UCB case study covering their experience and on-going approach to providing access to patients post clinical trial.
Unlicensed Medicines – Global Access
Video
20 Feb 2018
Novartis case study covering the challenges and solutions to implementing a clear and comprehensive corporate policy...
Unlicensed Medicines – Managed Access
Insight Blog
20 Dec 2017
Early access to orphan medicines – a glimpse into the future
Unlicensed Medicines – Managed Access
Insight Blog
01 Dec 2017
Early Access to Orphan Medicines: Highlights from the World Orphan Drug Congress Barcelona, 2017
Unlicensed Medicines – Managed Access
Webinar
25 Jul 2017
Addressing Key Challenges Through Access to Unlicensed Medicines
Unlicensed Medicines – Managed Access
Insight Blog
10 Jul 2017
Busting 5 common myths around access to unlicensed medicines
Clinigen Consulting
Insight Blog
19 Jun 2017
21st Century Cures Act: Does a public expanded access policy actually mean improved access for patients?
Unlicensed Medicines – Global Access
Article
01 Jun 2017
Access to Unlicensed Medicines - EAHP 2017 Satellite Symposium Report